InvestorsHub Logo
Followers 12
Posts 1099
Boards Moderated 0
Alias Born 06/07/2018

Re: None

Wednesday, 09/26/2018 1:36:58 PM

Wednesday, September 26, 2018 1:36:58 PM

Post# of 82995
NASDAQ uplisting isn't dependent on the Farm Bill; it's dependent on the exchange's opinion. CVSI imports their hemp from Europe, and the US has been importing hemp for years and processing it. The DEA was recently sued, and they confirmed that hemp products are legal. The FDA, in a briefing based on clinical trials from GW Pharma, stated that CBD has negligible abuse potential; however, they didn't say that Epidiolex has negligible abuse potential; I repeat, they said CBD has negligible abuse potential, which makes its schedule 1 status UNTENABLE. See it in the link below. I feel that CVSI is likely to pass the NASDAQ test whether we get a Farm Bill or not this year, which would also, like the Farm Bill, open up the flood gates to institutional investors. I don't have much concern here whatsoever. Also, the Farm Bill must pass to help struggling farmers, and if it doesn't, then 2019 it is, and the farmers will just have to struggle for another year thanks to inaction in Congress, but I don't think anyone wants that. CVSI is an amazing company with Godlike financials, and I believe it will be a titan in the industry in the future. I am holding Long Term, and I plan to do so for maybe 10 years or longer. At that point, we'll probably be looking at nice dividend payouts to shareholders once sales eventually plateau. With only 5% market penetration in the mega US market (20X the size of Canada's), there is still plenty of room to grow. I expect 40X growth of CVSI (minimum) within the next 4 years.

FDA Briefing Document on CBD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News